Key result
Cardiac resynchronisation therapy is established for specific heart failure subpopulations, but its potential use in a wider range of patients requires further investigation.
This article discusses the potential to expand cardiac resynchronization therapy indications to a wider range of heart failure patients, including those with narrow QRS complexes.
CRT indications should remain restricted to established subgroups; leaves open expansion to wider heart failure populations pending new trials.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2013) conducted an editorial in Heart failure. Cardiac resynchronisation therapy was evaluated. Cardiac resynchronisation therapy is established for specific heart failure subpopulations, but its potential use in a wider range of patients requires further investigation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: